Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • US warns that Israel risks ‘strategic defeat’ unless it protects civilians in Gaza
    • US, UK and Australia move to track ‘emerging threats’ in space
    • Israel-Hamas truce talks stall after Mossad negotiators leave Qatar
    • Israel plans for ‘long war’ and aims to kill top three Hamas leaders
    • Luis Caputo takes on Argentina’s worst economic crisis in decades
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • UN climate talks have focused on renewable energy for too long, Exxon chief says
      • Richard Branson rules out further investment in Virgin Galactic
      • Somerset Capital Management hit by loss of its largest client
      • Signa sold prized KaDeWe property at cut price
      • Israel-Hamas truce talks stall after Mossad negotiators leave Qatar
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • UN climate talks have focused on renewable energy for too long, Exxon chief says
      • Somerset Capital Management hit by loss of its largest client
      • HMRC urges crypto holders to disclose gains
      • Wall Street ‘fear gauge’ tumbles as investors spy end of Fed’s inflation fight
      • Charlie Munger and the Magnificent Seven
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The untimely death of the funeral
      • Should we believe Americans when they say the economy is bad?
      • Charlie Munger and the Magnificent Seven
      • Nvidia played its way to the domination of AI
      • The only way out of the Gaza impasse requires global effort
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
      Most Read
      • Why companies are tapping the boardroom for their next CEO
      • Are workplace romances a savvy investment?
      • How alcohol became a crutch for professional women
      • Desks by the hour: why flexible offices are a hit with business
      • The people defending humanity from AI can’t even write a decent press release
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The FT’s 25 most influential women of 2023
      • Celebrity lawyer David Sherborne: ‘I regard myself as on the side of the angels’
      • For women in wine, things are not getting better
      • Is the American dream really dead?
      • How to design a home for entertaining
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Coronavirus treatment

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Wednesday, 22 November, 2023
      AstraZeneca PLC
      AstraZeneca fights accusations its Covid-19 jab was ‘defective’

      Vaccine recipient claims he suffered side effect of severe blood clot

      A health worker prepares a dose of the AstraZeneca Covid-19 vaccine
    • Wednesday, 15 November, 2023
      FT SeriesTech Champions
      Airfinity gives decision makers big picture on health

      Covid may have abated, but emerging diseases and new drug categories are keeping the analytics firm busy

      Portrait of Airfinity founder Rasmus Bech Hansen
    • Monday, 6 November, 2023
      BioNTech
      BioNTech cuts revenue forecast on lower demand for Covid jabs

      German group slashes guidance by €1bn and reduces spending as it expects fewer first vaccine doses and lower boosting

      A patient receiving a vaccine dose
    • Thursday, 2 November, 2023
      Moderna
      Moderna shares hit by quarterly loss and waning Covid vaccine demand

      Biotech blames weaker US sales after lowering full-year forecast

      Syringes with needles in front of Moderna’s logo
    • Tuesday, 17 October, 2023
      Disease control and prevention
      Global warning system essential to beat future pandemics, says Cepi chief

      Call for rapid detection comes as pharma groups criticise draft WHO treaty on how to avoid another health crisis

      Richard Hatchett
    • Monday, 16 October, 2023
      BioNTech
      BioNTech writes down €900mn on Covid-19 vaccines

      Biotech group hit by lower demand, with majority of write-offs relating to raw materials bought during pandemic

      A dose of the BioNtech/Pfizer Covid vaccine is administered to a person at a vaccination centre
    • Sunday, 15 October, 2023
      Covid-19 vaccines
      EU delays approval of Novavax’s revised Covid jab

      US biotech has been struggling to overcome fall in demand for coronavirus jabs

    • Monday, 9 October, 2023
      Covid antivirals lose spark as regulatory scrutiny increases

      Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments

      A person dressed in a white clinical coat holds a box of the pills up in front of a larger cardboard box containing dozens more samples
    • Wednesday, 4 October, 2023
      Covid-19 vaccines
      Moderna reports trial success for dual Covid and flu vaccine

      Combined jab as effective as separate shots in early stage tests

      The Moderna Covid-19 vaccine is loaded into a syringe
    • Tuesday, 3 October, 2023
      News in-depthPfizer Inc
      Covid vaccine winners suffer reversal of fortune

      Companies have yet to provide investors with convincing post-pandemic strategies

      A montage of a nurse preparing a Covid-19 Pfizer vaccine, and the BioNTech and Moderna logos
    • Monday, 2 October, 2023
      Disease control and prevention
      WHO approves second malaria jab for children

      Oxford university shot expected to deliver ‘sufficient’ supply for all at-risk infants

      A child sits under a mosquito net
    • Monday, 2 October, 2023
      Nobel prizes
      Scientists whose work led to Covid mRNA vaccines win Nobel Prize

      Katalin Karikó and Drew Weissman praised for role in ‘unprecedented rate of development’ of coronavirus jabs

      Katalin Karikó and Drew Weissman
    • Tuesday, 26 September, 2023
      Covid-19 vaccines
      EU in talks with Moderna over new vaccine supply deal

      Brussels launches talks for mRNA jabs to augment existing contract with BioNTech/Pfizer

      A pharmacist administers a Covid jab made by Moderna
    • Monday, 25 September, 2023
      Covid antiviral drug linked to ‘transmissible’ mutations, research finds

      Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient

      An experimental COVID-19 treatment pill, called molnupiravir
    • Thursday, 14 September, 2023
      Special Report
      FT Health: Communicable Diseases

      Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments

      a tiger mosquito on a person’s skin
    • Wednesday, 13 September, 2023
      Anjana Ahuja
      The rush to outpace Covid variants

      At least three descendants of Omicron have scientists on alert and vaccination programmes speeding up

      Andy Carter illustration of a man running away from coronavirus proteins while pushing a shopping trolley with a vaccine syringe in it
    • Monday, 11 September, 2023
      Covid-19 vaccines
      FDA approves new Covid-19 boosters from Pfizer and Moderna

      Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US

      A nurse fills a syringe with Covid-19 vaccine
    • Wednesday, 6 September, 2023
      Covid-19 vaccines
      Latest vaccines help tackle highly mutated new Covid variant

      Preliminary studies find exposure to prevalent XBB.1.5 strain elicits antibodies to BA.2.86

      A medical worker holds a syringe of the Moderna vaccine
    • Wednesday, 30 August, 2023
      Covid-19 vaccines
      England brings forward Covid booster vaccinations to counter new sub-variant

      Potential mutations prompts authorities to begin immunisation rollout in September

      A woman receives an injection
    • Wednesday, 30 August, 2023
      ExplainerCoronavirus
      ‘We haven’t seen the end of Covid’: surge in cases to test health systems

      As vaccines are tweaked while new sub-variants emerge, the virus cannot be treated yet as a seasonal bug

      Health workers wear face masks as they walk out of a government hospital in Chennai, India
    • Thursday, 17 August, 2023
      Covid-19 vaccines
      Jonathan Van-Tam takes role at vaccine maker Moderna

      Prominent figure in UK pandemic response becomes medical consultant at pharma group

      Sir Jonathan Van-Tam
    • Sunday, 6 August, 2023
      News in-depthResearch and development
      UK better prepared for next pandemic, say top scientists

      New vaccines centre supports aim to develop jab for any new potential killer pathogen within 100 days

      Scientists at the Vaccine Development and Evaluation Centre at Porton Down
    • Friday, 21 July, 2023
      UK labour disputes
      Unions call off London Underground strikes after ‘intense’ talks

      Move by RMT, Unite and Aslef comes as stoppage by top NHS doctors in England ends without resolution

      Commuters at Bank station
    • Thursday, 20 July, 2023
      FT Magazine
      How a squad of MAGA warriors flush with cash turned on each other

      A doctor, a model and a boxer raised millions from Covid sceptics and anti-vaxxers. Then a knock-down, drag-out brawl broke out

    • Saturday, 1 July, 2023
      John Gapper
      Three warnings about the obesity pills coming after Wegovy

      New treatments have had remarkable results but there are reasons to be cautious

      An advertisement for Wegovy weight loss injections in the New York subway
    Previous page You are on page 1 Next page

    Recommended

    Covid-19 vaccines
    Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
    Covid-19 vaccines
    Covid vaccine development: The shots available and the doses administered
    Covid-19 vaccines
    In graphics: the UK vaccine supply chain
    Coronavirus: free to read
    Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence
    Coronavirus tracker

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Israel-Hamas war
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
      • Artificial intelligence
      • Semiconductors
      • Cyber Security
      • Social Media
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In